We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

124 hedge funds and large institutions have $968M invested in Genomic Health, Inc. in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 43 increasing their positions, 47 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

9% more capital invested

Capital invested by funds: $892M → $968M (+$76.1M)

9% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 47

7% less funds holding

Funds holding: 133 → 124 (-9)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

Holders
124
Holders Change
-9
Holders Change %
-6.77%
% of All Funds
3.09%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
14
Increased
43
Reduced
47
Closed
16
Calls
$375K
Puts
–
Net Calls
+$375K
Net Calls Change
+$374K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$69.4M
2
CWAM
Columbia Wanger Asset Management
Illinois
+$9.83M
3
Renaissance Technologies
Renaissance Technologies
New York
+$4.63M
4
AL
AJO LP
Pennsylvania
+$4.45M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.75M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$10.1M
2
Morgan Stanley
Morgan Stanley
New York
-$2.77M
3
CCMH
Cornerstone Capital Management Holdings
New York
-$1.7M
4
BIM
Bogle Investment Management
Massachusetts
-$1.62M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACP
126
Aveo Capital Partners
Colorado
– -$588K -20,000 Closed
Acadian Asset Management
127
Acadian Asset Management
Massachusetts
– -$564K -19,172 Closed
Susquehanna International Group
128
Susquehanna International Group
Pennsylvania
– -$539K -18,206 Closed
VRS
129
Virginia Retirement Systems
Virginia
– -$453K -15,400 Closed
Capstone Investment Advisors
130
Capstone Investment Advisors
New York
– -$346K -11,797 Closed
GC
131
Globeflex Capital
California
– -$316K -10,749 Closed
DTL
132
Dynamic Technology Lab
Singapore
– -$288K -9,801 Closed
HCM
133
Highbridge Capital Management
New York
– -$274K -9,327 Closed
VKH
134
Virtu KCG Holdings
New York
– -$265K -9,033 Closed
NCCM
135
Nine Chapters Capital Management
New Jersey
– -$203K -6,900 Closed
PCM
136
Prelude Capital Management
New York
– -$156K -5,300 Closed
NIT
137
NumerixS Investment Technologies
British Columbia, Canada
– -$118K -4,000 Closed
TRCT
138
Tower Research Capital (TRC)
New York
– -$27K -907 Closed
Mitsubishi UFJ Asset Management
139
Mitsubishi UFJ Asset Management
Japan
– -$19K -631 Closed
SSB
140
Sandy Spring Bank
Maryland
– -$9K -320 Closed
2 3 4 5
6

GHDX Hedge Fund Activity: Q1 2017 in Review

124 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q1 2017, worth a combined $968M — up 8.5% from $892M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GHDX and 14 opened new positions — a net loss of 2 holders — while 47 trimmed existing stakes and 43 added.

The largest buyer was BlackRock, adding an estimated $69.4M. The largest seller was Millennium Management, cutting an estimated $10.1M.

  • 124 institutional investors held Genomic Health, Inc. (GHDX) as of Q1 2017, down from 133 in Q4 2016.
  • Funds reported $968M of Genomic Health, Inc. stock for Q1 2017, up 8.5% quarter-over-quarter.
  • 14 funds opened new Genomic Health, Inc. positions in Q1 2017 and 16 closed out, a net change of -2 holders.
  • The largest Genomic Health, Inc. buyer in Q1 2017 was BlackRock, an estimated $69.4M added.
  • The largest Genomic Health, Inc. seller in Q1 2017 was Millennium Management, an estimated $10.1M sold.

Based on aggregated 13F filings for Q1 2017.